Mark leads the Biotechnology team at Carpmaels & Ransford. Mark’s impressive Biotech-only practice focusses on the rapid and effective building of commercially valuable European patent portfolios for small and medium-sized clients. Mark enjoys devising and implementing pragmatic drafting, filing, prosecution and defense strategies for the European Patent Office, in close collaboration with his long-standing clients. Mark also has a proven track record in co-ordinating large global patent portfolios for the firm’s clients, most notably Ionis Pharmaceuticals.